Isolated bone marrow mastocytosis: An underestimated subvariant of indolent systemic mastocytosis

Haematologica

Volumn 96, Issue 3, 2011, Pages 482-484

  Zanotti, Roberta ^a   Bonadonna, Patrizia ^a   Bonifacio, Massimiliano ^a   Artuso, Anna ^a   Schena, Donatella ^a   Rossini, Maurizio ^a   Perbellini, Omar ^a   Colarossi, Sabrina ^b   Chilosi, Marco ^a   Pizzolo, Giovanni ^a  

^a UNIVERSITY HOSPITAL OF VERONA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Anaphylaxis; Bone marrow mastocytosis; Skin involvement

Indexed keywords

TRYPTASE;

ADULT; AGED; ANAPHYLAXIS; BONE MARROW MASTOCYTOSIS; CONTROLLED STUDY; EARLY DIAGNOSIS; ENZYME BLOOD LEVEL; FEMALE; FLOW CYTOMETRY; HEPATOSPLENOMEGALY; HUMAN; HUMAN TISSUE; INDOLENT SYSTEMIC MASTOCYTOSIS; LABORATORY TEST; LETTER; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MAST CELL; SEX DIFFERENCE; SKIN DEFECT; SMOLDERING SYSTEMIC MASTOCYTOSIS; SYSTEMIC MASTOCYTOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANAPHYLAXIS; BONE MARROW; CELL PROLIFERATION; DIAGNOSIS, DIFFERENTIAL; EARLY DIAGNOSIS; FEMALE; HUMANS; ITALY; MALE; MAST CELLS; MASTOCYTOSIS, SYSTEMIC; MIDDLE AGED; PROGNOSIS;

EID: 79952346791     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.034553     Document Type: Letter

References (11)

1. Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25(7):603-25.
2. Horny HP, Metcalfe DD, Bennett JM, Bain BJ, Akin C, Escribano L, et al. Mastocytosis. In: Swerdlow SH, Campo E, Harris NL, et al, eds. WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. 4th ed. Lyon (France): IARC Press; 2008:54-63.
3. Bonadonna P, Zanotti R, Müller U. Mastocytosis and insect venom allergy. Curr Opin Allergy Clin Immunol. 2010;10(4):347-53.
4. Bonadonna P, Perbellini O, Passalacqua G, Caruso B, Colarossi S, Dal Fior D, et al. Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels. J Allergy Clin Immunol. 2009;123(3):680-6.
5. Johansson SG, Bieber T, Dahl R, Friedmann PS, Lanier BQ, Lockey RF, et al. Revised nomenclature for allergy for global use: report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 2004;113 (5):832-6.
6. Sonneck K, Florian S, Müllauer L, Wimazal F, Födinger M, Sperr WR, Valent P. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome. Int Arch Allergy Immunol. 2007;142(2):158-64.
7. Akin C, Scott LM, Kocabas CN, Kushnir-Sukhov N, Brittain E, Noel P, Metcalfe DD. Demonstration of an aberrant mast cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis. Blood. 2007;110(7):2331-3.
8. Pardanani A, Lim KH, Lasho TL, Finke CM, McClure RF, Li CY, et al. WHO subvariants of indolent mastocytosis: clinical details and prognostic evaluation in 159 consecutive adults. Blood. 2010;115(1):150-1.
9. Pardanani A, Tefferi A. Proposal for a revised classification of systemic mastocytosis. Blood. 2010;115(13):2720-1.
10. Metcalfe DD, Schwartz LB. Assessing anaphylactic risk? Consider mast cell clonality. J Allergy Clin Immunol. 2009;123(3):687-8.
11. Alvarez-Twose I, González de Olano D, Sánchez-Muñoz L, Matito A, Esteban-López MI, Vega A, et al. Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol. 2010;125(5):1269-78.